The observation that Siglecg is highly expressed in LADAM while Siglec-10 (the human homolog of Siglec-G), is associated with late-stage AD pathologies exhibiting robust Aβ and Tau deposition, further supports the view that Siglec10 signaling underlies the activation of LADAM in AD. Here, MAPT is linked to Alzheimer disease.